Robotic IV compounding comes to UMass

Hazardous IV prep is becoming an automated process at the UMass Memorial Medical Center in Massachusetts. The hospital is using the CytoCare robot from healthcare services provider and drug wholesaler McKesson to automate the compounding of intravenous drugs.

The robotic system lessons staff exposure to toxic agents in the hospital pharmacy, which handles about 5,000 IV products per month. That compounding load was spread across 11 pharmacists, says a release.

CytoCare boasts HL7 interfaces. And it has a continuous production flow feature that aids in planning sterile-prep schedules and in complying with quality and safety regulations.

- see the UMass release
- here's a video

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.